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Song KS, Choi YH, Kim JM, Lee H, Lee TJ, Yoon JH. Suppression
of prostaglandin E2-induced MUC5AC overproduction by RGS4 in the
airway. Am J Physiol Lung Cell Mol Physiol 296: L684–L692, 2009. First
published February 6, 2009; doi:10.1152/ajplung.90396.2008.—The
mechanism by which E-prostanoid (EP) receptor is critically involved
in PGE2-induced mucin 5AC (MUC5AC) gene expression in the
airway has been unclear. Furthermore, there have been little reports
regarding the negative regulatory mechanism and/or proteins that
affect PGE2-induced MUC5AC overproduction. In the present study,
we found that PGE2 induced MUC5AC gene expression in a dose-
dependent manner (EC50: 73.31  3.13 nM) and that the EP2/4-
specific agonist, misoprostol, increased MUC5AC mRNA level,
whereas the EP1/3-specific agonist, sulprostone, had no effect. Inter-
estingly, the cAMP concentration (685.1  14.9 pM) of the EC50
value of EP4-mediated cAMP production was much higher than that
of EP2 (462.33  23.79 pM), suggesting that EP4 has higher sensi-
tivity to PGE2 compared with EP2. Moreover, PGE2-induced Muc5ac
overproduction was much increased in regulator of G protein signal-
ing (Rgs) 4 knockout (KO) mice compared with wild-type mice at
both transcriptional and translational levels, and it was dramatically
suppressed in Rgs4 KO mice that had been infected with lentivirus
expressing RGS4 (lenti::RGS4) compared with lentivirus expressing
enhanced green fluorescent protein (lenti::eGFP). Finally, we demon-
strate that PGE2 can induce MUC5AC overproduction via the EP4
receptor and that RGS4 may have suppressive effects in controlling
MUC5AC overexpression in the airway. These findings may provide
a molecular paradigm for the development of novel drugs for respi-
ratory diseases.
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MUCINS are heavily glycosylated, high molecular weight glyco-
proteins produced by the epithelia of the respiratory, gastroin-
testinal, and reproductive tracts (25, 35). Twenty-one mucin
genes have been identified; however, it has been unclear how
mucins are regulated by various stimulants and are secreted in
respiratory diseases (6). Of these, mucin 5AC (MUC5AC) is
one of the major mucin genes in the human respiratory tract,
and MUC5AC mRNA levels are known to be upregulated by
proinflammatory cytokines, LPS, neutrophil elastase, cigarette
smoking, or reactive oxygen species (15, 19, 31, 32, 36) via
various signaling pathways. Nonetheless, there have been few
reports on the negative regulatory mechanisms that affect
stimulant-induced MUC5AC gene expression in the airway.
PGE2, one of the major prostaglandins produced, is a ver-
satile eicosanoid that regulates key responses in numerous
physiological and pathological processes, including angiogen-
esis, tumorigenesis, immune modulation, and inflammatory
airway diseases (7, 33). PGE2 exerts its biological functions
through E-prostanoid (EP) cell surface receptors. EP1-4 recep-
tors couple to Gq, Gs, Gi, and Gs, respectively, and can
activate or inhibit several signaling proteins resulting in the
increased formation of secondary messengers. Recently, Gray
et al. (14) reported EP2 and EP4 may be the major receptors for
IL-1-induced MUC5AC gene expression by producing PGE2
in the normal human tracheobronchial epithelial cells, and Kim
et al. (20) suggested that EP4 is essential for PGE2-induced
MUC5AC secretion in normal human nasal epithelial (NHNE)
cells. However, the exact mechanism by which EP receptor is
critically involved in PGE2-induced MUC5AC gene expression
has been unclear. Furthermore, we wanted to find a negative
regulator of PGE2-induced MUC5AC gene expression at the
EP receptor level.
We thought a member of regulators of G protein signaling
(RGS) proteins may play as a negative regulator of PGE2-
induced MUC5AC gene expression since RGS proteins can
stimulate the G protein GTPase activity and thereby produce
desensitization (deactivation). RGS proteins are defined by a
shared 120-amino acid domain that binds directly to activated
G subunits (3) and act as tightly regulated modulators and
integrators of G protein signaling. A protein domain, known as
the RGS box, harbors GTPase-accelerating proteins (GAP)
activity and is the defining feature of RGS proteins. Outside the
RGS box, the presence of other protein domains diversifies the
range of protein interactions and regulatory activities of RGS
proteins. Binding of RGS proteins to active G (GTP-bound)
can interfere with effector-binding proteins, thereby blocking
activation and downstream signaling (16). In addition, the
expression of RGS2, -3, -5, and -16 subtypes, mainly members
of R4 RGS subfamily, has been defected in the lung (22, 26).
In the airway, which RGS protein has a critical role and how the
interplay between EP receptor and RGS leads to the alteration of
MUC5AC overproduction remain poorly understood.
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In the present study, we examined the mechanism by which
PGE2 increases MUC5AC overproduction at the receptor level.
We show that the EP4 receptor plays as an important role in
PGE2-induced MUC5AC overproduction in the airway. In
addition, RGS4 suppressed PGE2-induced MUC5AC overpro-
duction both in vitro and in vivo by binding to EP4-coupled
Gs depending on GTPS.
MATERIALS AND METHODS
Materials. All chemical compounds were purchased from Cayman
Chemical (Ann Arbor, MI). Gs and G antibodies were purchased
from Calbiochem (Merck; Darmstadt, Germany), RGS4 and actin
antibodies were purchased from Santa Cruz Biotechnology (Santa
Cruz, CA), and MUC5AC antibody was purchased from Lab Vision
(Fremont, CA). The cDNA expression constructs encoding EP4, Gs,
Gs Q227L, RGS2, RGS3, RGS4, and RGS5 were purchased from
the UMR cDNA Resource Center (Rolla, MO). All of small interfer-
ing RNAs (siRNAs) were synthesized from Bioneer (Daejeon, Ko-
rea): EP4, 5-UUCUUUCCAGGCUAUGUAU (dTdT)-3; RGS4, 5-
GGAUCAGCUGUGAAGAGUA (dTdT)-3; and negative control,
5-CCUACGCCACCAAUUUCGU (dTdT)-3.
Cell cultures. NHNE cells (2  105 cells/well) were seeded in 0.5
ml of culture medium on Transwell clear culture inserts (24.5 mm,
0.45-m pore size; Costar, Cambridge, MA). Cells were cultured in a
1:1 mixture of BEGM and DMEM containing all the supplements
previously described (39). Human tissue was maintained in accor-
dance with the guidelines and approval of the institutional review
board of Yonsei University, Seoul, Korea. Consent from both patients
and the local ethics committee was obtained for use of the specimens.
The human lung mucoepidermoid carcinoma cell line (NCI-H292)
was purchased from the American Type Culture Collection (CRL-
1848; Manassas, VA) and cultured in RPMI 1640 (Invitrogen;
Carlsbad, CA) supplemented with 10% fetal bovine serum in the
presence of penicillin-streptomycin at 37°C in a humidified cham-
ber with 5% CO2.
Cell transfection. Cells were plated in 6-well plates 1 day before
transfection with plasmid DNA (1 g/well) or siRNA (100 pmol/well)
using FuGENE 6 (Roche; Indianapolis, IN) according to the manu-
facturer’s instructions. Approximately 24 h after transfection, cells
were maintained in 0.2% serum RPMI media for 16–18 h before
treatment with PGE2 and then harvested 24 h after treatment.
Measurement of cAMP level. Cells were plated in 6-well plates 1
day before transfection. Approximately 24 h after transfection, trans-
fected cells were replated at 2,000/well in 96-well plates and main-
tained in 0.2% serum RPMI media for 16–18 h before treatment with
PGE2. cAMP production was measured according to the manufacturer’s
instructions (Promega; Madison, WI).
PCR. After reverse transcription, RT-PCR was performed to amplify
DNA fragments. All of EP primers (18) were synthesized from Bioneer.
PCR products were run for 35 cycles using the amplification conditions
(18). Real-time PCR was performed using a Bio-Rad iCycler iQ Detec-
tion System (Bio-Rad, Hercules, CA) with iQ SYBR Green Supermix.
The following primers were used: human MUC5AC, forward 5-
CAGCCACGTCCCCTTCAATA-3 and reverse 5-ACCGCATTT-
GGGCATCC-3; 2-microglobulin, forward 5-CGCTCCGTGGCCT-
TAGC-3 and reverse 5-GAGTACGCTGGATAGCCTCCA-3; mouse
Muc5ac primers, forward 5-CCATGCAGAGTCCTCAGAACAA-3
and reverse 5-TTACTGGAAAGGCCCAAGCA-3; and mouse
GAPDH primers, forward 5-TGTGTCCGTCGTGGATCTGA-3 and
reverse 5-CCTGCTTCACCACCTTCTTGAT-3 (34). Parameters were
95°C for 10 min, followed by 40 cycles of 95°C for 15 s and 60°C for
60 s. The result was normalized against 2-microglobulin as an
internal control (mouse GAPDH for Muc5ac mRNA), and the
relative quantity of MUC5AC mRNA was determined using a
MUC5AC standard curve.
Western blot analysis, dot blot analysis, and immunoprecipitation.
These methods were described previously (32). NCI-H292 cells were
grown to confluence in 6-well plates. After treatment with PGE2, the
cells were lysed with 2 lysis buffer [250 mM Tris HCl (pH 6.5), 2%
SDS, 4% 2-mercaptoethanol, 0.02% bromphenol blue, 10% glycerol].
Equal amounts of whole cell lysates from protein samples were
resolved by 10% SDS-PAGE and transferred to a polyvinylidene
difluoride membrane (PVDF; Millipore, Bedford, MA). For dot blot
analysis, 125 l of protein lysates were directly diluted with dot blot
buffer (600 mM KSCN, 10 mM EDTA, pH 8.0) in 96-well plates.
After serial dilution, lysates were applied by vacuum using a dot blot
apparatus. The membrane were incubated with MUC5AC antibody as
primary antibody and then incubated with anti-mouse horseradish
peroxidase IgG. The signal was detected by enhanced chemilumines-
cence kit, and the relative fold increase was calculated by dividing
stimulant-treated signal into control signal since there is no commer-
cially available MUC5AC protein for standardization. The data were
represented as means SD of triplicate cultures from the independent
experiments. For immunoprecipitation, cells were transfected with
either wild-type Gs or dominant negative Gs Q227L mutant and
RGS4-expressing constructs using FuGENE 6. Following transfec-
tion, cells were washed with ice-cold PBS and harvested by scraping
into lysis buffer [25 mM HEPES, 150 mM NaCl, 0.5% Nonidet P-40,
1 mM EDTA, 1 mM EGTA, protease inhibitor tablet (Complete
Mini; Roche)], sonicated (4 times each for 5 s), and centrifuged at
12,000 g for 15 min. Supernatant lysates (230 l) were precleared
with GammaBind G Sepharose (GE Healthcare; Uppsala, Sweden)
for 30 min at 4°C. Following centrifugation, anti-Gs antisera were
added to precleared lysates, incubated for 14 h at 4°C, and added
GammaBind G Sepharose.
Mice, genotyping, and tracheotomy. Six- to eight-week-old
C57BL/6 mice and RGS4 knockout (KO) mice (B6-129P2-
Rgs4tm1Dgen/J; The Jackson Laboratory; Bar Harbor, ME) were
maintained in accordance with the guidelines and under approval
of the Animal Care Committee of Yonsei University, Seoul, Korea.
Mice were anesthetized with Zoletil (30 mg/kg). Genotyping of
Rgs4tm1Dgen/tm1Dgen mice was performed by PCR on genomic tail
DNA using an endogenous gene-specific primer (5-GGACAT-
GAAACATCGGCTGGGGTTC-3), an endogenous and targeted
gene-specific primer (5-CCATCTTGACCCAAATCTGGCT-
CAG-3), and targeted neo primer (5-GGGCCAGCTCATTC-
CTCCCACTCAT-3), which produced a 226-bp and a 484-bp band
from the wild-type and the targeted allele, respectively. For intra-
tracheal instillation, the trachea was surgically exposed after an-
esthetization by making an incision in the neck skin. A microsy-
ringe carrying a 31-gauge needle filled with PGE2 solution was
used for injection into the exposed trachea. PGE2 (50 l; 0.5, 1.0,
or 5.0 mg/kg) was injected into the lumen of each trachea. After
injection, the skin was sutured. At 1 day after injection, the mouse
was killed, and the trachea was removed (34).
Virus production and in vivo intranasal instillation for infection.
Vector construction and virus production of LentiM1.2::RGS4-eGFP,
LentiM1.2::eGFP, and small hairpin (sh) Lenti3.4R::RGS4 (5-CT-
GAGAACCTTAGCCATCA-3) were performed by Macrogen (Seoul,
Korea). Viruses [5  105 transduction units (TU)/50 l] were adminis-
tered drop by drop to the right nostril of anesthetized mice using sequencing
tips (27). Three days after infection, tracheotomy was performed.
Statistical analysis. The data represent the means  SD for at least
three independent experiments. Where appropriate, the statistical
differences were assessed by Wilcoxon Mann-Whitney test. A P value
0.05 was considered statistically significant.
RESULTS
PGE2-induced MUC5AC gene expression was mediated via
the EP4 receptor in NHNE cells. To determine whether PGE2
increases MUC5AC gene expression in NHNE cells, real-time
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PCR analysis was performed. As seen in Fig. 1A, PGE2
induced MUC5AC gene expression in a dose-dependent man-
ner with an EC50 value of 73.31  3.13 nM. Since Kunikata
et al. (21) reported that endogenous PGE2 played an important
feedback function in allergic inflammation, and we thought
that newly synthesized endogenous prostaglandins by exoge-
nous PGE2 might influence the results, we wanted to rule out
this effect. Accordingly, indomethacin, a nonselective cyclo-
oxygenase-1 (COX-1) and COX-2 inhibitor, was employed to
investigate the function of exogenous PGE2. Cells were treated
for 24 h with PGE2 alone or pretreated indomethacin (3 M)
for 1 h before PGE2 treatment. Indomethacin alone had no
effect, and pretreatment of indomethacin did not affect PGE2-
induced MUC5AC gene expression (Fig. 1B). This result sug-
gests that MUC5AC gene expression have been affected by
exogenous PGE2 but not endogenous PGE2 in the present
study. We next examined whether mRNA level of EP receptors
was affected by PGE2. All of EP receptors were expressed, and
treatment with PGE2 did not affect EP receptor gene expres-
sion in NHNE cells (Fig. 1C). To identify which EP receptors
are involved in PGE2-mediated MUC5AC gene expression,
cells were treated for 24 h with the EP1/3-selective agonist,
sulprostone, or the EP2/4-selective agonist, misoprostol (Fig.
1D; Ref. 14). Misoprostol (10 M) increased MUC5AC
mRNA level, whereas 10 M sulprostone had no effect. This
result indicates that EP2 and/or EP4 were (was) involved in
PGE2-induced MUC5AC gene expression. Moreover, to iden-
tify which EP receptor has a substantial role in MUC5AC gene
expression, a nonselective EP2 antagonist, AH6809 (20, 30),
and a selective EP4 antagonist, GW627368X (37, 38), were
used (Fig. 1E). The increase in MUC5AC gene expression by
PGE2 treatment (7.33-fold) is decreased by 	42.1% on addi-
tion of AH6809 (4.25-fold), whereas GW627368X inhibited
	73.6% (1.94-fold) of it. This result suggests that both EP2
and EP4 receptors are probably related to PGE2-induced
MUC5AC gene expression in NHNE cells. However, in our
previous study, EP4 receptor played as a major receptor for
PGE2-induced MUC5AC production at the transcriptional and
translational levels (20). Accordingly, we selected the EP4
receptor as a major receptor in the present study. To comple-
ment this pharmacological approach, we used the genetic
strategy of siRNA in NCI-H292 cells. As shown in Fig. 1F,
siRNA EP2 and siRNA EP4 suppressed intracellular EP2 and
EP4 mRNA level in NCI-H292 cells, respectively. Consistent
with the pharmacological study, the increase in MUC5AC gene
expression by PGE2 treatment (7.19-fold) was decreased by
	53.0% on addition of siRNA EP2 (3.42-fold), whereas
siRNA EP4 inhibited 	71.3% (2.09-fold) of increased
MUC5AC gene expression. These results suggest that both
EP2 and EP4 receptors are probably related to PGE2-induced
MUC5AC gene expression. However, the EP4 receptor served
as a major receptor in PGE2-induced MUC5AC gene expres-
sion.
PGE2-mediated Gs activity was dependent on the EP4
receptor. Next, to identify which EP receptor has a critical role
in PGE2 signaling, the ligand selectivity of PGE2 was exam-
ined using cAMP production assay. NCI-H292 cells were
transiently transfected with EP2, EP4, or mock construct.
PGE2-induced cAMP production was higher in cells trans-
fected with EP4 construct compared with cells transfected with
EP2 construct (Fig. 2A). The cAMP concentration (685.1 
14.9 pM) of the EC50 value of EP4-mediated cAMP production
was much higher than that of EP2 (462.33  23.79 pM) (Fig.
2B), suggesting that EP4 has higher sensitivity to PGE2 com-
pared with EP2. It also indicated that that PGE2 increases Gs
activity in a dose-dependent manner and that the EP4 receptor
appears to have more functional activity than the EP2 receptor,
at least in part in NCI-H292 cells. To verify that the concen-
tration of cAMP increased by PGE2 was mediated by EP4,
siRNA EP4 was employed. Whereas PGE2-induced cAMP
production was higher in cells transfected with wild-type EP4
construct compared with cells treated with PGE2 alone, PGE2-
induced cAMP production was significantly suppressed by
siRNA EP4 construct in a dose-dependent manner (Fig. 2C).
These results indicate that PGE2-mediated Gs activity was
dependent on the EP4 receptor.
RGS4 could regulate PGE2-induced MUC5AC gene expres-
sion by interaction with Gs in a GTPS-dependent manner.
The main aim of this study is to identify specific molecule(s)
that suppresses PGE2-induced MUC5AC overproduction dur-
ing airway mucosal inflammation. We therefore screened in-
hibitory G protein molecules that attenuate G protein signaling.
We checked the inhibitory effects of RGS proteins containing
GTPase activity on MUC5AC gene expression. It has been
reported that mainly R4 RGS family proteins (RGS2, -3, -5,
and -16), containing only RGS domain, are expressed in the
lung (22, 26). Of these RGS proteins, because RGS16 has been
upregulated in germinal center and activated T cells, suggest-
ing that it has a role in adaptive immunity (8), we have
excluded RGS16 from this study, and selected RGS2, -3, -4,
and -5 proteins. Since these RGS subtype constructs have been
tagged with hemagglutinin (HA), Western blot analysis was
performed with anti-HA antibody. No change was detected in
the expression of HA in cells transfected with each RGS
construct (Fig. 3A, top). Of the RGS proteins tested, only
ectopic RGS4 expression inhibited PGE2-induced MUC5AC
gene expression (Fig. 3B, bottom). To determine a potential
role for RGS4 in PGE2-mediated MUC5AC gene expression,
siRNA RGS4 was employed. Whereas wild-type RGS4 dra-
matically suppressed PGE2-induced MUC5AC gene expres-
sion, siRNA RGS4 much increased PGE2-induced MUC5AC
gene expression compared with PGE2 alone (Fig. 3B). This
phenomenon is due to the inhibition of endogenous RGS4
expression. In addition, to investigate a potential role for the
RGS4 in Gs-mediated signal processing, we asked whether
RGS4 bound to Gs as a component of the G protein complex.
If so, we thought that RGS4 could negatively regulate
MUC5AC gene expression by binding to the Gs-mediated
signaling complex. To verify this possibility, NHNE cells were
infected with lentiviruses (multiplicity of infection 30) express-
ing wild-type RGS4 and shRGS4 (Fig. 3C). On day 3 after
infection, RGS4 and Gs were coimmunoprecipitated by the
addition of GTPS, and this reaction was disrupted by the
addition of GDP. G was dissociated from the Gs-RGS4
complex by addition of GTPS in cell lysates and was used as
a positive control for GTP (Fig. 3C). These results suggest that
RGS4 has an inhibitory effect on PGE2-induced MUC5AC
gene expression by binding to Gs in vitro.
RGS4 plays as a negative regulator molecule for PGE2-
dependent Muc5ac gene expression in vivo. To determine the
in vivo relevance of in vitro results, approximately 6- to
8-wk-old male C57BL/6 mice were tested. The trachea of mice
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Fig. 1. PGE2 induces MUC5AC gene expression via the
E-prostanoid (EP) receptor 4 (EP4) in normal human nasal
epithelial (NHNE) and human lung mucoepidermoid carci-
noma (NCI-H292) cells. A: NHNE cells were treated for
24 h with several concentrations of PGE2. Cell lysates were
harvested for real-time quantitative PCR. Corresponding
dissociation curves for standard (0.01 fg to 1 ng; Aa) and
samples (Ab) were amplified using specific primers with
SYBR Green dye. These curves were merged on the same
panel (Ac). B: NHNE cells were treated for 1 h with 3 M
indomethacin (indo), a cyclooxygenase-1 (COX-1) and
COX-2 inhibitor, before treatment for 24 h with 100 nM
PGE2. Cell lysates were harvested for real-time quantitative
PCR. *P  0.05 compared with control. C: NHNE cells
were treated with 100 nM PGE2 for 24 h. The presence of
EP receptors mRNA was detected by RT-PCR with specific
EP receptors primers, respectively. D: NHNE cells were
treated for 24 h with 100 nM PGE2, 10 M EP1/3 agonist,
sulprostone, or 10 M EP2/4 agonist, misoprostol. Cell
lysates were performed real-time quantitative PCR. *P 
0.05 compared with control. E: NHNE cells were treated for
1 h with either 10 or 50 M EP2 antagonist, AH6809, or 10
or 50 M EP4 antagonist, GW627368X, before treatment
for 24 h with 100 nM PGE2. Cell lysates were harvested for
real-time quantitative PCR. *P  0.05 compared with
PGE2 alone. F: NCI-H292 cells transfected with construct
encoding wild-type EP2 or EP4, small interfering RNA
(siRNA) EP2 or EP4, or siRNA control were treated for 24 h
with 100 nM PGE2. Cell lysates were harvested for PCR.
*P  0.05 compared with PGE2 alone and **P  0.05
compared with overexpressed EP2 or EP4. All data shown
are representative of 3 independent experiments. Tm, melt-
ing temperature; 2M, 2-microglobulin; WT, wild-type;
siEP2, siRNA EP2; sicon, siRNA control.
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was surgically exposed under general anesthesia and aseptic
conditions, and 50 l of 0.1, 1.0, and 5.0 mg/kg PGE2 was
intratracheally instilled with a 31-gauge needle. After 24 h,
PCR and dot blotting for Muc5ac expression were performed
using the trachea from the killed mice (Fig. 4, A and B). PGE2
increased MUC5AC expression in vivo at both the transcrip-
tional and translational levels. These results were consistent
with the in vitro results. In addition, to investigate whether
RGS4 has an effect on PGE2-induced Muc5ac expression in
vivo, Rgs4 KO mice were employed. After Rgs4tm1Dgen/tm1Dgen
mice were genotyped by PCR with genomic tail DNA using
specific primers, which produced a 226-bp and a 484-bp band
from the wild-type and the targeted allele, respectively (data
not shown), tracheotomy was performed for PGE2 instillation.
Twenty-four hours later, total RNA and tissue lysates were
purified from the trachea of Rgs4 KO mice. PGE2-induced
Muc5ac expression was much increased in Rgs4 KO mice
compared with wild-type mice at both the transcriptional and
translational levels (Fig. 4, C and D), indicating that RGS4
probably has a suppression effect on PGE2-induced Muc5ac
overproduction in the airway. We thought that when
lenti::RGS4 virus administrate into Rgs4 KO mice, it may
restore lost RGS function in PGE2-induced Muc5ac overpro-
duction in the airway. Lentivirus expression system was used.
Viruses (5  105 TU/50 l) were administrated in the right
nostril of anesthetized mice drop by drop using sequencing tips
(27). Three days after infection, the trachea was surgically
exposed to instill PGE2. RGS4 was well-expressed in Rgs4 KO
mice that had been infected with lenti::RGS4-eGFP (Fig. 4E,
top). PGE2 instillation to the trachea of Rgs4 KO mice that had
been infected with lenti::RGS4-eGFP resulted in a fourfold
decrease of Muc5ac expression compared with lenti::Mock-eGFP
(Fig. 4E, bottom), indicating that administration of RGS4 to
Rgs4 KO mice airway restores its suppressive function in Rgs4
KO mice. These results were consistent with in vitro results
(Fig. 3B), and an inhibitory effect of RGS4 on Muc5ac over-
production was revealed by knocking out RGS4. Next, to
investigate whether EP4 is responsible for PGE2-induced
Muc5ac gene expression in vivo, wild-type mice were injected
with the EP4-specific agonist, PGE1-OH, and expression level
of Muc5ac mRNA was determined. After the mice were
preinjected with 1.0, 2.5, and 5.0 mg/kg GW627368X (ip) for
1 h, PGE1-OH or PGE2 was instilled intratracheally. The EP4
agonist increased Muc5ac mRNA level, whereas the mRNA
level strongly inhibited GW627368X in a dose-dependent
manner, and PGE2-induced mRNA level was also inhibited by
GW627368X (Fig. 4F), indicating that EP4 receptor is essential
for PGE2-induced Muc5ac overproduction. These results sug-
gest that PGE2 binds to the EP4 receptor thereby inducing
MUC5AC overproduction, and RGS4 may be a key negative
regulator during airway mucosal inflammation.
Fig. 2. EP4 is essential for PGE2-induced
MUC5AC gene expression through Gs acti-
vation. A: cells were transiently transfected
with construct expressing wild-type EP4, wild-
type EP3, or pcDNA3.1 as the transfection
control. Cells were serum-starved overnight
and then treated with the indicated concentra-
tions of PGE2 for 6 h, after which the cAMP
production was measured. The values shown
are means  SD of experiments performed in
triplicate. B: we compared the cAMP concen-
trations of the EC50 values of EP2- and EP4-
mediated cAMP production. *P  0.05 com-
pared with PGE2 concentration of EC50 values
of EP2. C: cells were transiently transfected
with constructs expressing either 0.01, 0.1, or
1.0 g/well of wild-type EP4 or 1, 10, 100
pmol/well of siRNA EP4. Six hours after PGE2
treatment (10 nM), the luciferase activity was
measured and normalized to the X-gal activity.
*P  0.05 compared with PGE2 alone. All
data shown are representative of 3 independent
experiments.
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DISCUSSION
PGE2 is frequently observed at high concentrations at the
sites of inflammation and plays physiological roles in the
regulation of mucosal immunity (9). Secreted PGE2 stimulates
epithelial cells in an autocrine and paracrine fashion. Epithelial
cells thereby increase mucin secretion and mucin gene expres-
sion, including MUC5AC and MUC8 (20). Interestingly, even
though the importance of PGE2 in human airway epithelium is
well-established (29), the molecular mechanism by which
PGE2-induced MUC5AC overproduction is regulated is still
unclear. The focus of the present study was to identify molec-
ular mechanism(s) and regulatory molecule(s) for PGE2-in-
duced MUC5AC overproduction.
In the present study, we showed that PGE2 induced
MUC5AC mRNA expression in NHNE cells, whereas endog-
enously produced or endocrinal PGE2 did not affect MUC5AC
gene expression during exogenous PGE2 treatment (Fig. 1B).
Interestingly, even if the half-life of PGE2 is very short (10),
PGE2 had an effect in the early stage during the 24-h treatment
period. The fact that MUC5AC gene expression increases at
12 h after the beginning of PGE2 exposure can be attributed to
PGE2 binding to its receptors in the early stage. It seems that
the kinetics of PGE2 in the early stage is sufficient to induce
MUC5AC gene expression because activated receptor propa-
gates specific signaling to amplify physiological PGE2 signal-
ing. The biological actions of PGE2 are mediated by seventh
transmembrane EP receptors (23). Using RT-PCR, we found
that all EP receptor mRNAs were expressed and PGE2 treat-
ment did not affect EP receptor gene expression in NHNE cells
(Fig. 1C). In the airway, EP2 and EP4 receptors have been
known as major receptors for MUC5AC gene expression and
secretion (14, 20). Consistent with this result, the EP2/4-selec-
tive agonist (misoprostol) had a significant effect on MUC5AC
gene expression (Fig. 1D), whereas the EP1/3-selective agonist
(sulprostone) had no effect. These results suggest that either
the simultaneous induction of the two different Gs-coupled
PGE2 receptors plays a pivotal role for PGE2 during airway
mucosal inflammation or both EP2 and EP4 may cooperatively
work as a compensatory system for MUC5AC gene expression.
Among these receptors, however, the EP4-specific antago-
nist has much more inhibited PGE2-induced MUC5AC gene
expression than the EP2 antagonist (Fig. 1E). Even if the
pharmacokinetics of the two different drugs has been consid-
ered deeply, this suggests that EP4 may be more closely related
to PGE2 signaling at least in part in NHNE cells. Consistent
with the pharmacological data, knockdown of EP4 suppressed
PGE2-induced MUC5AC gene expression (Fig. 1F). We won-
dered what is different between EP2 and EP4 despite them both
Fig. 3. Regulator of G protein signaling-4
(RGS4) plays as a suppressor of PGE2-induced
MUC5AC gene expression by interacting with
Gs depending on GTPS in vitro. A: NCI-H292
cells were transiently transfected with construct
expressing wild-type RGS2, -3, -4, or -5, respec-
tively. Confluent cells were serum-starved over-
night and then treated with 100 nM PGE2 for 24 h
followed by Western blotting with hemagglutinin
(HA) antibody (top) and PCR (bottom). *P 
0.05 compared with PGE2 alone. B: cells were
transiently transfected with construct expressing
wild-type RGS4, siRNA RGS4 (siRGS4), or
siRNA control. Cells were serum-starved and
treated with 100 nM PGE2 for 24 h, after which
cell lysates were harvested for Western blot anal-
ysis with anti-RGS4 IgG (top) and real-time PCR
(bottom). *P  0.05 compared with PGE2 alone.
C: 3 days after NHNE cells were infected with
lentivirus expressing enhanced green fluorescent
protein (eGFP), wild-type RGS4, or small hairpin
(sh) RGS4, cell lysates were preincubated with
100 M GDP or 100 M GTPS/25 mM MgCl2
at 24°C for 30 min before immunoprecipitation
(IP) against Gs. The input lane contains 

volume used for IP. IB, immunoblotting. G was
used as positive control for GTPS. Data shown
are representative of 3 independent experiments.
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being the same Gs-coupled receptors. One reason may be due
to a difference in their ligand selectivity of PGE2. Despite
almost the same mRNA expression levels of the receptors,
cAMP production of the EC50 value of EP4-mediated cAMP
production was about 685.1  14.9 pM (Fig. 2A), whereas that
of EP2-mediated cAMP production was 462.33  23.79 pM
following PGE2 treatment (Fig. 2B). This indicates that the
higher cAMP concentration of the EC50 value of EP4-mediated
cAMP production is because of high selectivity of PGE2 to
convey signaling efficiently to coupled signaling pathways.
Consistent with our results, Fujino et al. (11, 12) reported that
EP4 receptor strengthens an association of the PGE2 to induce
T cell factor and early growth response factor-1 in inflamma-
tion. Another possible reason that there is a difference in
Fig. 4. RGS4-dependent attenuation of
MUC5AC overproduction in the airway.
A: 50 l of 0.1, 1.0, or 5 mg/kg PGE2 or
saline was instilled in the trachea of
C57BL/6 mice. Twenty-four hours later,
mouse tracheal tissue was processed for
real-time PCR and dot blot analysis with
anti-MUC5AC IgG (B). Saline was used as
a vehicle. *P  0.05 compared with saline-
treated mice. C: 50 l of 1.0 mg/kg PGE2
or saline was instilled inside the trachea of
the genotyped mice. Twenty-four hours
later, trachea was processed for real-time
PCR and dot blot analysis with anti-
MUC5AC IgG (D). *P  0.05 compared
with PGE2-treated wild-type mice. E: either
lenti::eGFP or lenti::RGS4-eGFP [5  105
transduction units (TU)/50 l] was admin-
istered drop by drop to the right nostril.
Three days after infection, 50 l of 1.0
mg/kg PGE2 or saline was instilled inside
the trachea. Twenty-four hours later, tra-
cheas were processed for PCR. *P  0.05
compared with PGE2-treated Rgs4 knockout
mice infected by lenti::eGFP. F: genotyped
mice were injected with DMSO as a vehicle
for different dosages of the EP4 antagonist,
GW627368X (1–5 mg/kg ip), for 1 h before
instillation of the EP4-specific agonist,
PGE1-OH (50 l of 5 mg/kg it), and PGE2
(50 l of 1.0 mg/kg). Tracheas from killed
mice were harvested for real-time PCR. *P 
0.05 compared with PGE1-OH-treated wild-
type mice. All data shown are representative
of 3 independent experiments.
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biological actions of EP2 and EP4 may be due to posttransla-
tional modifications, such as glycosylation, hydroxylation,
methylation, nucleotidylation, and phosphorylation. Our think-
ing was supported by several studies that a charged residue(s)
in the seventh transmembrane domain and posttranslational
modification sites were involved in receptor activation and
desensitization (1, 2, 13, 24).
The main finding of this study is that RGS4 suppressed
PGE2-induced Gs-mediated signaling in vitro and in vivo by
enhancing GTPase acceleration. Until now, there has been no
report of a relationship between PGE2 receptors and RGS in
mucin-related literature. Despite that the characterized main
function of RGS proteins is GTPase-activating proteins for
Gi/o, Gq, or G12/13 classes of G proteins, no interaction
between RGS and Gs has been found (40). Recently, Castel-
lone et al. (4) reported that the Gs-GTP bound axin protein
contained an RGS domain, and thus PGE2 was able to promote
colon cancer cell growth. In addition, Zheng et al. (40) sug-
gested that the RGS domain of RGS-PX1 specifically inter-
acted with Gs, thereby accelerating its GTP hydrolysis, which
leads to an attenuation of Gs-mediated signaling in bovine
brain lysates. In the present study, RGS4 bound Gs-GTP,
thereby attenuating PGE2-induced MUC5AC overproduction.
In addition, the dynamics of heterotrimeric G protein signaling
complex are regulated by RGS4 protein in GTP-dependent
manner (Fig. 3C). To address the role of RGS4 protein in the
pathogenesis of anti-inflammation in the airway, a gain/loss-
of-function study in an animal model must be considered.
PGE2 instillation into Rgs4 KO mice much increased Muc5ac
overproduction compared with that in wild-type mice (Fig. 4,
C and D), and Rgs4 function has been restored and Muc5ac
gene expression was suppressed after administration of RGS4-
expressing lentivirus into Rgs4 KO mice (Fig. 4E). These
results demonstrate that RGS4, a classical R4 RGS superfamily
lacking any additional well-defined domains (3), negatively
regulates the Gs-mediated signaling that induced Muc5ac
production during airway mucosal inflammation. These results,
however, raise an interesting question. Why does only RGS4
function in the airway epithelium? We just thought that spec-
ificity may be mediated in part through selectivity of RGS
proteins for particular G protein substrates (17) or that post-
translational modification of NH2-terminal domain except pal-
mitoylation may be required for the plasma membrane associ-
ation of RGS4. In fact, although RGS2 does not have an
inhibitory function (Fig. 3A), it is similar in its NH2-terminal
structure to RGS4, including an amphipathic -helical mem-
brane targeting domain (5, 17). In addition, although it has
been known that RGS4 and RGS2 are the most likely to be
involved in regulation of signaling by receptors coupled to Gq
pathways (28), RGS4 inhibited Gs pathway in the present
study. These findings support our hypothesis that either the
difference of the physiological functions of RGS2 and RGS4
may due to posttranslational modifications on NH2- or COOH-
terminal domain, excluding RGS box, or that some mediating
(bridging) protein(s) may regulate the ability of RGS4 protein
like a small switching molecule when it (they) senses the
multiplicity of different signaling pathways during airway
inflammation. In the present study, we used mice trachea to
detect differences in Muc5ac overproduction in Rgs4/ and
Rgs4/ mice but not lung and selected 24 h as Muc5ac
overproduction peaked at 24 h. Although 24 h may be suffi-
cient to express Muc5ac in goblet cells before inducing inflam-
matory cell infiltration or mucous metaplasia, it may be not
enough to induce inflammatory cell infiltration or mucous
metaplasia in the airway.
Taken together, these findings suggest that PGE2 may inter-
act directly with EP4 receptor, resulting in increased MUC5AC
overproduction. The ability of RGS4 proteins to interact with
Gs is important to negatively regulate PGE2-induced MUC5AC
overproduction in the airway. As more mechanistic insights are
obtained, identification of an RGS accessory molecule that
regulates RGS function may be considered.
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